LIPO — Lipella Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $1.43m
- -$0.43m
- $0.54m
- 20
- 38
- 15
- 12
Annual cashflow statement for Lipella Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.062 | -1.87 | -2.6 | -4.62 | -5.02 |
| Depreciation | |||||
| Non-Cash Items | 0.065 | 0.679 | 0.757 | 1.48 | 0.949 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.032 | 0.198 | 0.01 | -0.009 | 0.113 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.029 | -0.989 | -1.83 | -3.15 | -3.95 |
| Capital Expenditures | — | — | — | -0.014 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | -0.301 | 0.301 | 0 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -0.301 | 0.301 | -0.014 | 0 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.609 | 2.1 | 5.24 | 1.34 | 2.84 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.581 | 0.807 | 3.71 | -1.83 | -1.11 |